Watch Live

Tweet TWEET

Elsevier and the American College of Cardiology Announce the Launch of a New Journal JACC: Heart Failure

 Elsevier and the American College of Cardiology Announce the Launch of a New
                         Journal JACC: Heart Failure

  PR Newswire

  NEW YORK, March 5, 2013

NEW YORK, March 5, 2013 /PRNewswire/ --

                    First publication now available online

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, and the American College of Cardiology
(ACC) are pleased to announce that the American College of Cardiology (ACC )
journals' portfolio has been expanded with the launch of JACC: Heart Failure .
This new journal will better meet the demands and challenges of treating what
is now the most rapidly increasing category of cardiac disease. The first
publication is now available online at heartfailure.onlinejacc.org .

Christopher O'Connor, MD, FACC will serve as Editor-in-Chief of JACC: Heart
Failure . Each bi-monthly issue will present high-quality content, authored by
experts worldwide, with a unique focus on new research and treatment options.
It is destined to take its place among the top journals in the world for the
understanding of the pathophysiology, diagnosis, treatment, and care of heart
failure patients with the intent to improve our understanding of the disease,
clinical trials, clinical outcomes, and advances in therapies through
scientific communication.

A state-of-the-condition update by Dr. Eugene Braunwald and the breadth of
articles featured in the first issue are an example of the journal's aims to
publish the full range of topics related to this condition - including basic
and translational science, trials and registries, co-morbidities, biomarkers,
advanced heart failure, and outcomes.

"The addition of JACC: Heart Failure to ACC's current portfolio will help meet
the need for more research in this growing field," said ACC President William
Zoghbi, MD, FACC. "With the increasing rate of patients suffering from heart
failure, the science presented in this new journal will give cardiologists
access to valuable new research."

"We are delighted to be publishing JACC: Heart Failure in collaboration with
the ACC," says Cynthia Baudendistel, Executive Publisher for the ACC journals
at Elsevier. "We look forward to seeing the impact this journal will make on
cardiology practice, research, teaching, and advocacy."

For more information or to submit an article, go to:
heartfailure.onlinejacc.org or jaccsubmit-heartfailure.org

About the American College of Cardiology (ACC)

The mission of the American College of Cardiology is to transform
cardiovascular care and improve heart health. The college is a 40,000-member
medical society comprised of physicians, surgeons, nurses, physician
assistants, pharmacists and practice managers. The college is a leader in the
formulation of health policy, standards and guidelines. The ACC provides
professional education, operates national registries to measure and improve
quality of care, disseminates cardiovascular research, and bestows credentials
upon cardiovascular specialists who meet stringent qualifications.
cardiosource.org/ACC .

About ACC's portfolio of journals

Journal of the American College of Cardiology (JACC)

As the leader in its field, JACC publishes original peer-reviewed clinical and
experimental reports on all aspects of cardiovascular disease. Topics covered
include coronary artery and valve disease, congenital heart defects, vascular
surgery, cardiomyopathy, drug treatment, new diagnostic techniques, findings
from the laboratory, and large multicenter studies of new therapies.
content.onlinejacc.org

JACC: Cardiovascular Imaging

JACC: Cardiovascular Imaging provides readers with a broad, balanced view of
all aspects of cardiovascular imaging. The journal includes original clinical
research on non-invasive and invasive imaging techniques including
echocardiography, CT, CMR, nuclear, optical imaging, and cine-angiography.
Advances in basic science and molecular imaging which are likely to
substantially influence the clinical practice of medicine in the next decade
(in diagnostic performance, understanding of the athogenetic basis of the
disease, and therapy) are also featured. Other content will emphasize imaging
for the practicing cardiologist, advocacy and practice management, and
state-of-the-art reviews. imaging.onlinejacc.org

JACC: Cardiovascular Interventions

JACC: Cardiovascular Interventions encompasses the entire field of
interventional cardiovascular medicine, including cardiac (coronary and
non-coronary) peripheral and cerebrovascular interventions. JACC:
Cardiovascular Interventions publishes studies that will impact the practice
of interventional cardiovascular medicine including: Clinical trials that
provide evidence to inform and alter practice guidelines; experimental studies
that point to improved technologies and mechanistic understanding; and
in-depth discussions of topics of interest by respected experts in the field.
interventions.onlinejacc.org 

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
provider of professional information solutions in the Science, Medical, Legal
and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and
Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Rachael Zaleski Elsevier +1-215-239-3658 rachel.zaleski@elsevier.com